HHS hopes to work with Congress to stem drug shortages by setting up a program to rate the quality and supply chain resiliency of generic drugs and then incentivize hospitals through Medicare payments and penalties to contract for drugs with high scores and institute programs to protect against shortages. The move comes after industry experts and generic drug lobbies pushed the idea of changing hospital buying patterns through long-term contracts that include a pay-for-performance mechanism. HHS released a white paper...